arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Tenon Medical, Inc.

TNON

$0.13 ▼ -0.03 (-20.39%) at close

6 Visible periods

23 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Tenon Medical, Inc. faces fundamental challenges. The fundamentals warrant careful consideration of downside risks.

Market Cap —

Dividend Yield —

Revenue Growth 20.4% ↗

Op. Margin -324.3% ↗

ROIC -200.5% ↘

FCF / Share —

Trailing P/E —

Price / Book 0.3x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

6-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$3.94M

↑ +20.4% —

Net Income Profit after all expenses

$-12.56M

↑ +8.2% —

Operating Margin Operating profit as % of sales

-324.3%

↑ +22.8% 0th

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Revenue Growth YoY (%)	20.4% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+154%)	11.9% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+49%)	323.7% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+3947%)	331.9% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+4048%)	—	—
EPS Growth YoY (%)	84.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	83.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-2808.5% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	69.8% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—
Net Income Growth YoY (%)	8.2% Fair ↑ Fair Improving Year-over-year change in net income	12.2% Fair ↑ Fair Improving Year-over-year change in net income	17.6% Good Good Year-over-year change in net income	-168.4% Weak Weak Year-over-year change in net income	—	—
Revenue CAGR 3Y (%)	78.7% Excellent Excellent Compound annual revenue growth over 3 years	173.6% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Operating Margin (%) (%)	-324.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2262%)	-420.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2901%)	—	—	—	—
Profit Margin (%) (%)	-318.4% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2753%)	-417.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3577%)	—	—	—	—
FCF Margin (%) (%)	-279.4% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-307.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-428.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—
FCF / Net Income (x)	0.88x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.68x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.62x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Return on Invested Capital (%)	-200.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-182.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-1597.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-236.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	24.8% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-118.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-139.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-247.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-168.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	-69.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-249.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1761%)	-229.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1627%)	—	—	34.3% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+129%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Interest Coverage (x)	—	—	—	-52.90x Weak Weak Operating income divided by interest expense Optimal: > 5x	-10.40x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-3.76M	$-6.54M	$-2.43M	$-2.13M	$-2.92M	—

📊 What does each share earn? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Basic EPS, GAAP (USD)	$-1.70	$-11.26	$-68.64	$-2.36	$-7.81	—
Book Value per Share (USD)	$0.46	$1.90	$2.39	$0.56	$-20.76	—
Tangible Book Value per Share (USD)	$0.20	$1.90	$2.39	$0.56	$-20.76	—
Basic Weighted Avg Shares (shares)	7,384	1,214	227	8,008	903	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Working Capital (USD)	$3.56M	$6.34M	$749.00K	$6.82M	$-7.60M	—
Total Equity (USD)	$5.04M	$5.97M	$778.00K	$6.25M	$-20.55M	$-2.71M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Sales/Revenue/Turnover (USD)	$3.94M	$3.28M	$2.93M	$691.00K	$160.00K	—
Depreciation Expense (USD)	$238.00K	$395.00K	$193.00K	$78.00K	$2.00K	—
Net Income, GAAP (USD)	$-12.56M	$-13.67M	$-15.58M	$-18.92M	$-7.05M	—
Operating Cash Flow (USD)	$-10.74M	$-9.88M	$-12.18M	$-12.03M	$-4.29M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 6 years · 22 quarters

Tenon Medical, Inc.

Analytical Summary

6-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare TNON with peers